317 related articles for article (PubMed ID: 19785033)
21. An integrated in silico analysis of drug-binding to human serum albumin.
Estrada E; Uriarte E; Molina E; Simón-Manso Y; Milne GW
J Chem Inf Model; 2006; 46(6):2709-24. PubMed ID: 17125211
[TBL] [Abstract][Full Text] [Related]
22. Method dependence of apparent stoichiometry in the binding of salicylate ion to human serum albumin: a comparison between equilibrium dialysis and fluorescence titration.
Ozer I; Tacal O
Anal Biochem; 2001 Jul; 294(1):1-6. PubMed ID: 11411999
[TBL] [Abstract][Full Text] [Related]
23. Effect of albumin conformation on the binding of ciprofloxacin to human serum albumin: a novel approach directly assigning binding site.
Ahmad B; Parveen S; Khan RH
Biomacromolecules; 2006 Apr; 7(4):1350-6. PubMed ID: 16602760
[TBL] [Abstract][Full Text] [Related]
24. The extraordinary ligand binding properties of human serum albumin.
Fasano M; Curry S; Terreno E; Galliano M; Fanali G; Narciso P; Notari S; Ascenzi P
IUBMB Life; 2005 Dec; 57(12):787-96. PubMed ID: 16393781
[TBL] [Abstract][Full Text] [Related]
25. Histidine146 of human serum albumin plays a prominent role at the interface of subdomains IA and IIA in allosteric ligand binding.
Kaneko K; Chuang VT; Minomo A; Yamasaki K; Bhagavan NV; Maruyama T; Otagiri M
IUBMB Life; 2011 Apr; 63(4):277-85. PubMed ID: 21488149
[TBL] [Abstract][Full Text] [Related]
26. Paclitaxel-HSA interaction. Binding sites on HSA molecule.
Trynda-Lemiesz L
Bioorg Med Chem; 2004 Jun; 12(12):3269-75. PubMed ID: 15158795
[TBL] [Abstract][Full Text] [Related]
27. Binding of δ9-tetrahydrocannabinol and diazepam to human serum albumin.
Fanali G; Cao Y; Ascenzi P; Trezza V; Rubino T; Parolaro D; Fasano M
IUBMB Life; 2011 Jun; 63(6):446-51. PubMed ID: 21557446
[TBL] [Abstract][Full Text] [Related]
28. Interaction of mitoxantrone with human serum albumin: spectroscopic and molecular modeling studies.
Khan SN; Islam B; Yennamalli R; Sultan A; Subbarao N; Khan AU
Eur J Pharm Sci; 2008 Dec; 35(5):371-82. PubMed ID: 18762252
[TBL] [Abstract][Full Text] [Related]
29. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
Hou T; Zhu L; Chen L; Xu X
J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
[TBL] [Abstract][Full Text] [Related]
30. Binding of warfarin influences the acid-base equilibrium of H242 in sudlow site I of human serum albumin.
Perry JL; Goldsmith MR; Williams TR; Radack KP; Christensen T; Gorham J; Pasquinelli MA; Toone EJ; Beratan DN; Simon JD
Photochem Photobiol; 2006; 82(5):1365-9. PubMed ID: 16563025
[TBL] [Abstract][Full Text] [Related]
31. Combined docking, molecular dynamics simulations and spectroscopic studies for the rational design of a dipeptide ligand for affinity chromatography separation of human serum albumin.
Aghaee E; Ghasemi JB; Manouchehri F; Balalaie S
J Mol Model; 2014 Oct; 20(10):2446. PubMed ID: 25220335
[TBL] [Abstract][Full Text] [Related]
32. Receptor flexibility in de novo ligand design and docking.
Alberts IL; Todorov NP; Dean PM
J Med Chem; 2005 Oct; 48(21):6585-96. PubMed ID: 16220975
[TBL] [Abstract][Full Text] [Related]
33. Detection of site-specific binding and co-binding of ligands to human serum albumin using 19F NMR.
Jenkins BG; Lauffer RB
Mol Pharmacol; 1990 Jan; 37(1):111-8. PubMed ID: 2300044
[TBL] [Abstract][Full Text] [Related]
34. High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE.
Rich RL; Day YS; Morton TA; Myszka DG
Anal Biochem; 2001 Sep; 296(2):197-207. PubMed ID: 11554715
[TBL] [Abstract][Full Text] [Related]
35. Experimental-like affinity constants and enantioselectivity estimates from flexible docking.
Gumede NJ; Singh P; Sabela MI; Bisetty K; Escuder-Gilabert L; Medina-Hernández MJ; Sagrado S
J Chem Inf Model; 2012 Oct; 52(10):2754-9. PubMed ID: 22946447
[TBL] [Abstract][Full Text] [Related]
36. Determining molecular binding sites on human serum albumin by displacement of oleic acid.
Sarver RW; Gao H; Tian F
Anal Biochem; 2005 Dec; 347(2):297-302. PubMed ID: 16289007
[TBL] [Abstract][Full Text] [Related]
37. Interaction studies of coumaroyltyramine with human serum albumin and its biological importance.
Neelam S; Gokara M; Sudhamalla B; Amooru DG; Subramanyam R
J Phys Chem B; 2010 Mar; 114(8):3005-12. PubMed ID: 20136105
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions.
Kawakami A; Kubota K; Yamada N; Tagami U; Takehana K; Sonaka I; Suzuki E; Hirayama K
FEBS J; 2006 Jul; 273(14):3346-57. PubMed ID: 16857017
[TBL] [Abstract][Full Text] [Related]
39. Novel binding studies of human serum albumin with trans-feruloyl maslinic acid.
Subramanyam R; Goud M; Sudhamalla B; Reddeem E; Gollapudi A; Nellaepalli S; Yadavalli V; Chinnaboina M; Amooru DG
J Photochem Photobiol B; 2009 May; 95(2):81-8. PubMed ID: 19230701
[TBL] [Abstract][Full Text] [Related]
40. Investigation of ketoprofen binding to human serum albumin by spectral methods.
Bi S; Yan L; Sun Y; Zhang H
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Jan; 78(1):410-4. PubMed ID: 21147021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
